Nautilus Biotechnology, Inc.
NAUT
$1.02
$0.010.99%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -1.43% | 9.71% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -1.06% | 4.54% | |||
| Operating Income | 2.24% | -4.54% | |||
| Income Before Tax | 1.55% | -6.65% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 1.55% | -6.65% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 1.55% | -6.65% | |||
| EBIT | 2.24% | -4.54% | |||
| EBITDA | 1.89% | -5.13% | |||
| EPS Basic | 1.98% | -6.42% | |||
| Normalized Basic EPS | 1.93% | -5.38% | |||
| EPS Diluted | 1.98% | -6.42% | |||
| Normalized Diluted EPS | 1.93% | -5.38% | |||
| Average Basic Shares Outstanding | 0.40% | 0.21% | |||
| Average Diluted Shares Outstanding | 0.40% | 0.21% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||